"GW Pharmaceuticals engages in the research, development and commercialization of a range of cannabinoid prescription medicines." read more

EMPLOYEE PARTICIPANTS: 11

TOTAL RATINGS: 111

CEO: Kevin Rountree

Kevin Rountree GW CEO Rating

GW's CEO, Kevin Rountree, has 10 employee ratings and a score of 76/100, placing them in the Top 15% of similar size companies on Comparably with 201-500 Employees and Top 15% of other companies in Minneapolis. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at GW rate Kevin Rountree higher than females, giving the CEO a score of 80/100.

Last updated months ago.

Where This Score Ranks GW's CEO Rating

TOP
15%
In the Top 15% of 2013 Similar Sized Companies on Comparably
TOP
15%
In the Top 15% of 77 Nearby Companies in Minneapolis
?
Not enough ratings to compare against competitors.

Apr

Dec

Jul

Oct

Jun

A-76 / 100

Jan

GW CEO Kevin Rountree Bio

Kevin Rountree serves as the CEO / President of GW.

Who Ranks GW's CEO Rating the Highest?

Gender - Male 80/100

Gender - Female 77/100

Department - Engineering 73/100

Who Ranks GW's CEO Rating the Lowest?

Experience - Entry Level 63/100

Tenure - Less than 1 Year 73/100

GW CEO Kevin Rountree At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at GW.

GW's CEO is highly regarded by Male employees, Female employees, and the Engineering department. However, employees with Entry Level experience and employees who have been at the company Less than 1 Year have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.